1. 湖南中医药大学第一附属医院
2. 湖南中医药大学
纸质出版:2016
移动端阅览
[1]谢海波,刘亚娟,汪典,卢青,罗尧岳,刘越美,陈旭.活血、破血药对动脉粥样硬化大鼠主动脉组织内源性凋亡途径的影响[J].中医杂志,2016,57(16):1411-1415.
XIE Haibo, LIU Yajuan, WANG Dian, et al. Effect of Blood-activating Drug and Stasis-breaking Drug on Endogenous Apoptotic Pathway of Aortic Tissue in Atherosclerosis Rats[J]. Journal of Traditional Chinese Medicine2016, 57(16): 1411-1415.
[1]谢海波,刘亚娟,汪典,卢青,罗尧岳,刘越美,陈旭.活血、破血药对动脉粥样硬化大鼠主动脉组织内源性凋亡途径的影响[J].中医杂志,2016,57(16):1411-1415. DOI: 10.13288/j.11-2166/r.2016.16.016.
XIE Haibo, LIU Yajuan, WANG Dian, et al. Effect of Blood-activating Drug and Stasis-breaking Drug on Endogenous Apoptotic Pathway of Aortic Tissue in Atherosclerosis Rats[J]. Journal of Traditional Chinese Medicine2016, 57(16): 1411-1415. DOI: 10.13288/j.11-2166/r.2016.16.016.
目的探讨活血药(当归、川芎)、破血药(三棱、莪术)改善动脉粥样硬化的可能作用机制。方法将60只大鼠随机分为空白组、模型组、他汀组、活血组、破血组
空白组8只
其余各组均13只。采用高脂饲料喂饲结合腹腔注射维生素D3法复制动脉粥样硬化大鼠模型。造模成功后
空白组、模型组灌服10 ml/(kg·d)白开水
活血组灌服当归、川芎煎液
破血组灌服三棱、莪术煎液
他汀组灌服阿托伐他汀钙
给药量均为1.8 g/(kg·d)
每天1次
连续4周。取主动脉组织
光镜下观察主动脉组织病理变化
免疫组化法检测主动脉组织细胞色素C(Cyt-C)及细胞凋亡诱导因子(AIF)蛋白的表达
原位杂交法检测主动脉组织半胱氨酸天冬氨酸蛋白酶3(Caspase-3)mRNA表达情况。结果与模型组比较
他汀组、活血组及破血组主动脉组织粥样硬化病变均有不同程度减轻
其中他汀组与破血组病变改善最为明显。与空白组比较
模型组主动脉组织Cyt-C、AIF蛋白及Caspase-3 mRNA表达显著增多(P<0.05
P<0.01);与模型组比较
他汀组、破血组主动脉组织Cyt-C、AIF蛋白及Caspase-3 mRNA表达均减少
活血组Cyt-C蛋白、Caspase-3 mRNA表达均减少(P<0.05或P<0.01);破血组主动脉组织Caspase-3 mRNA表达低于活血组(P<0.05)。结论活血药、破血药均能改善动脉粥样硬化
且破血药效果优于活血药;活血药可能通过抑制Cyt-C表达
降低Caspase-3 mRNA水平
破血药可能通过抑制Cyt-C表达
下调凋亡诱导因子AIF表达及降低Caspase-3 mRNA水平来抗动脉粥样硬化。
Objective To study the possible mechanism of blood-activating drug [Danggui( Angelicaesenensis Radix 当归) and Chuanxiong( Ligusticum Wallichii 川芎) ]and stasis-breaking drug [Sanleng( Rhizoma Sparganii 三棱) and Ezhu( Curcuma Zedoary 莪术) ]in improving atherosclerosis. Methods Sixty rats were randomly divided into a blank group
a model group
a statin group
a blood-activating group
and a stasis-breaking group. There were8 rats in the blank group
and 13 rats in each of the other groups. Rat model of atherosclerosis was established with high-fat diet combined with intraperitoneal injection with vitamin D3. After successfully modeling
10 ml /( kg·d) of boiled water was given to rats in the blank group and the model group
and 1. 8 g /( kg·d) of decoction of Danggui and Chuanxiong
decoction of Sanleng and Ezhu
or atorvastatin calcium were given to the rats in the blood-activating group
the stasis-breaking group and the statin group
respectively
once a day
for four weeks. Pathological changes of aortic tissue was observed under light microscope. Expression of cytochrome C( Cyt-C) and the apoptosis inducing factor( AIF) protein in aortic tissue were detected with immunohistochemical method
and the expression of cysteine aspartic protease 3( Caspase-3) mRNA in aortic tissue was detected using in-situ hybridization method. Results Compared with the model group
atherosclerosis of aortic tissue relieved in varying degrees in the statin group
the blood-activating group and the stasis-breaking group
especially in the statin group and the stasis-breaking group.Compared with the blank group
the expression of Cyt-C
AIF protein and Caspase-3 mRNA of aortic tissue increased significantly in the model group( P < 0. 05
P < 0. 01); Compared with the model group
the expression of Cyt-C
AIF protein
and Caspase-3 mRNA in aortic tissue decreased in the statin group and the stasis-breaking group
and the expression of Cyt-C and Caspase-3 mRNA decreased in the blood-activating group( P < 0. 05 or P < 0. 01); The expression of Caspase-3 mRNA in aortic tissue in the stasis-breaking group was lower than that in the blood-activating group( P < 0. 05). Conclusion Both blood-activating drug and stasis-breaking drug can improve atherosclerosis
and the effect of stasis-breaking drug is better than that of blood-activating drug; Blood-activating drug may inhibit the expression of Cyt-C and reduce the level of Caspase-3 mRNA to resist atherosclerosis. On this basis
stasis-breaking drug also may reduce the expression of apoptosis inducing factor AIF to resist atherosclerosis.
0
浏览量
210
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010102007558号